Efficacy and Safety of Upadacitinib in Patients with Active Psoriatic Arthritis and Inadequate Response to Biologic Disease-Modifying Anti-Rheumatic Drugs: A Double-Blind, Randomized Controlled Phase 3 Trial Genovese, M., Lertratanakul, A., Anderson, J. K., Papp, K., Tillett, W., Van den Bosch, F., Tsuji, S., Dokoupilova, E., Keiserman, M., Wang, X., Zhong, S., Zueger, P., Pangan, A., Mease, P. WILEY. 2020

View details for Web of Science ID 000587568501015